Journal Finder

The Iranian Journal of Immunology (I.J.I) is an internationally disseminated peer-reviewed publication andpublishes a broad range of experimental and theoretical studies concerned with all aspects of immunology.

Journal for ImmunoTherapy of Cancer is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.The journal welcomes submissions in the following areas and other related topics:Basic Tumor ImmunologyTumor antigens, innate and adaptive anti-tumor immune mechanisms, immune regulation, immune response, cancer and inflammation, preclinical models, chemotherapy and radiotherapy interactions with the anti-tumor immune responseClinical/Translational Cancer ImmunotherapyFirst-in-man clinical trials, phase II/III clinical studies, immune monitoring investigations, tumor microenvironment, host genetics and clinical outcomeImmunotherapy BiomarkersPredictive/prognostic biomarker studies, gene expression studies in cancer immunotherapy, serological immune biomarkers, multiparameter flow cytometry-defined immune biomarkers, high content immunohistological studiesReviews/EditorialsTriggering discussion on hot topics and innovative concepts

Journal for ImmunoTherapy of Cancer is the official journal of the Society for Immunotherapy of Cancer (SITC). The Society for Immunotherapy of Cancer (SITC) is a 501 (c)(3) non-profit society of medical professionals that was established in 1984 to exchange, encourage and promote information about the promise and breakthroughs of biological therapies, including immunotherapy, for patients with cancer. SITC is the world's leading member society of medical professionals dedicated to advancing cancer immunotherapy through its initiatives, educational sessions, and collaborative endeavors. The society has become THE forum for innovative discussions in the field.

The Journal of Allergy and Clinical Immunology publishes high-impact, cutting-edge clinical and translational research papers for allergists, immunologists, dermatologists, gastroenterologists, and other physicians and researchers interested in allergic diseases and clinical immunology. Articles cover such topics as asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases, and include clinical trials and mechanistic studies that report on novel therapies, insights into underlying mechanisms, and other discoveries that will inform our understanding of these diseases and ultimately improve the diagnosis and management of patients. With an impact factor of 12.047, the journal ranks 1st of 23 in the Allergy category and 7th of 135 in the Immunology category in the 2013 Journal Citation Reports®, published by Thomson Reuters. The Journal of Allergy and Clinical Immunology is also recommended for initial purchase in the Brandon-Hill study, Selected List of Books and Journals for the Small Medical Library.

Aims and ScopeJACI: In Practice covers the spectrum of conditions treated by allergist-immunologists in their practices. The emphasis of the journal is on information that is practical for clinicians-material that can be used in everyday practice or will help in acquiring new knowledge or skills that can be directly applied to patients. A major goal of JACI: In Practice is to provide our readers with a high level of evidence to support their clinical decisions in diagnosis and management. Content All JACI: In Practice content is peer-reviewed. The journal welcomes original research articles that fit into the above scope. For each original article, a highlight box indicates what is already known about this subject, what this study adds, and how the new information impacts current management guidelines. Shorter original research and instructive case reports are presented as Clinical Communications. "Images in Allergy" submissions that consist of clinical pictures (e.g., X-rays, CT scans, biopsies, allergens, endoscopic visualizations of the airway, eruptions, etc.) and impart important clinical information are also included. In addition, JACI: In Practice features various types of review articles that will primarily be invited by the editors. Many of these will offer CME. The original and review articles are supplemented by Editorials, AAAAI Practice Papers, and a regular Ask the Expert column.

The Journal of Antibiotics seeks to promote research on antibiotics and related types of medicinal substances. The journal will accept biochemical, chemical, microbiological and pharmacological studies. However, studies regarding human therapy do not fall under the journal's scope. Contributions regarding antibiotics and bioactive microbial products are particularly encouraged. Topics of particular interest within the journal's scope include, but are not limited to, those listed below: * Discovery of new antibiotics and related microbial products * Production, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related microbial products * Biosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related microbial products * Novel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related microbial products * Newly found properties, mechanisms of action and resistance-development of antibiotics and related microbial productsThe Journal of Antibiotics's original articles cover new theories and primary research. The journal also publishes regular short reviews, book reviews, and news and commentary articles.

The Journal of Autoimmunity publishes papers related to the diverse aspects of autoimmunity: the mechanism of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic autoantibody tests, and the epidemiology, pathophysiology, and treatment of autoimmune diseases. Special, but not exclusive, attention will be given to papers dealing with genetic, molecular biology, and cellular aspects of the discipline.Research Areas Include:• Underlying mechanisms of autoimmunity• Immunologic• Molecular• Cellular• Genetic• VirologicAreas of Clinical Interest:• Rheumatology• Dermatology• Endocrinology• Nephrology• Haematology• ImmunopharmacologySpecial issues:Suggestions for special issue topics and guest editors can be sent to Deirdre Dunne, d.dunne@elsevier.comBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The Journal of Clinical Immunology is an international journal that helps researchers and academic clinicians keep current on investigative basic immunology and diseases related to the immune system. This well-established journal publishes articles on basic, translational, and clinical studies in all aspects of immunology, including animal models of human diseases.

Journal of Cutaneous Immunology and Allergy publishes high quality peer-reviewed manuscripts covering the entire scope of cutaneous immunology and allergy, from molecular studies to clinical investigations and observations. JCIA is the official journal of The Japanese Society for Cutaneous Immunology and Allergy, and serves as an international forum for the work of all skin researchers and dermatological scientists.

Since its inception in 1896, The Journal of Experimental Medicine (JEM) has published papers on the physiological, pathological, and molecular mechanisms that encompass the host response to disease. The journal prioritizes studies on intact organisms and has made a commitment to publishing studies on human subjects.JEM originsThe JEM was founded in 1896 at the Johns Hopkins School of Medicine by William Welch, the school’s founder and also the first president of the Board of Scientific Directors of the Rockefeller Institute. From its inception, Welch edited the journal by himself—even editing manuscripts while attending baseball games—and he eventually found that it placed too heavy a burden on his time. By March 1902, the editorial burden became too great for Welch, who stopped publishing papers and began stockpiling manuscripts and unanswered correspondence in his office, explaining the conspicuous absence of published papers from 1902 to 1904 (see JEM Archives).In October 1902, Welch appealed to the board of The Rockefeller Institute to take over the journal. The transfer of ownership and publication responsibilities required the physical transfer of manuscripts from Welch’s office, which fell to the director of The Rockefeller Institute, Simon Flexner, who carried the abandoned manuscripts from Baltimore to New York in a suitcase.The first issue of the JEM published by The Rockefeller Institute appeared in February 1905, with Flexner serving as editor, and the journal has been published regularly since then. Although the journal was adopted by The Rockefeller Institute as a venue for publication of the Institute’s own research, it also accepted submissions from outside. Even in the early years, more than half of the papers published in the journal came from external labs. .

The Journal of Global Antimicrobial Resistance (JGAR) is a quarterly online journal run by an international Editorial Board that focuses on the global spread of antibiotic-resistant microbes. The Journal aims to track the resistance threat worldwide and to give a comprehensive view of how infectious disease experts are challenging the problem.Featuring peer-reviewed and up to date articles, reviews and short notes JGAR will cover the topical aspects of antimicrobial resistance proposing themes on:resistance mechanisms and gene transfer;antibacterial, antiviral, antifungal and antiparasitic resistance;microbiological and clinical studies stewardship;resistance to disinfectants;microbicides;antimicrobial resistance testing detection and diagnostic;PK/PD and resistancesurveillance studies of resistant pathogens affecting humans at the global level, isolated from different hosts and environments.

The Journal of Immunoassay & Immunochemistry is an international forum for rapid dissemination of research results and methodologies dealing with all aspects of immunoassay and immunochemistry, as well as selected aspects of immunology. They include receptor assay, enzyme-linked immunosorbent assay (ELISA) in all of its embodiments, ligand-based assays, biological markers of ligand-receptor interaction, in vivo and in vitro diagnostic reagents and techniques, diagnosis of AIDS, point-of-care testing, clinical immunology, antibody isolation and purification, and others. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

The Journal of Immunological Methods is devoted to covering techniques for: (1) Quantitating and detecting antibodies and/or antigens. (2) Purifying immunoglobulins, lymphokines and other molecules of the immune system. (3) Isolating antigens and other substances important in immunological processes. (4) Labelling antigens and antibodies. (5) Localizing antigens and/or antibodies in tissues and cells. (6) Detecting, and fractionating immunocompetent cells. (7) Assaying for cellular immunity. (8) Documenting cell-cell interactions. (9) Initiating immunity and unresponsiveness. (10) Transplanting tissues. (11) Studying items closely related to immunity such as complement, reticuloendothelial system and others. (12) Molecular techniques for studying immune cells and their receptors. (13) Imaging of the immune system. (14) Methods for production or their fragments in eukaryotic and prokaryotic cells.In addition the journal will publish articles on novel methods for analysing the organization, structure and expression of genes for immunologically important molecules such as immunoglobulins, T cell receptors and accessory molecules involved in antigen recognition, processing and presentation. Submitted full length manuscripts should describe new methods of broad applicability to immunology and not simply the application of an established method to a particular substance - although papers describing such applications may be considered for publication as a short Technical Note. Review articles will also be published by the Journal of Immunological Methods. In general these manuscripts are by solicitation however anyone interested in submitting a review can contact the Reviews Editor and provide an outline of the proposed review.A Computational Methods Section reflects the increasingly central role of sophisticated statistical and mathematical methods and computational models in the analysis, visualization, interpretation of the results of techniques and investigations within the general scope of the Journal.These methods can generally be divided into data-driven Immunomics methods involving high throughput assays or model-driven methods that provide a framework for data analysis, visualization, and interpretation. Descriptions of high-quality immunological databases are also of interest.This Section will publish papers that present important advances to current practice or new "gold standards" for mathematical and computational methods and analyses in the field of immunology. Areas of interest reflect the general areas of interest of the Journal, particularly novel methods for analyzing the organization, structure and expression of genes and proteins of immunologically important molecules such as immunoglobulins, T cell receptors, and various accessory molecules involved in antigen recognition, processing, and presentation, and inflammation.

The Journal of Immunotherapy publishes basic scientific and clinical studies of the immunologic response to tumors and other diseases. It addresses the latest advances in basic cytokine research (interferons, interleukins, and newly described factors); immune regulation; immune response to diseases and associated antigens; growth factors and their receptors; hematopoietic factors; monoclonal antibodies; therapeutic studies in animal models; immunotherapy research, including active immunization and adaptive immunotherapy in animal models and humans; and clinical trials. 160;.

TheJournal of Immunotoxicology is a peer-reviewed journal that provides a needed singular forum for the international community of immunotoxicologists, immunologists, and toxicologists working in academia, government, consulting, and industry to both publish their original research and be made aware of the research findings of their colleagues in a timely manner. Research from many subdisciplines are presented in the journal, including the areas of molecular, developmental, pulmonary, regulatory, nutritional, mechanistic, wildlife, and environmental immunotoxicology, immunology, and toxicology. Original research articles as well as timely comprehensive reviews are published. Read More: http://informahealthcare.com/page/imt/Description.

Journal of Inflammation welcomes research submissions on all aspects of inflammation. Please note that non-research articles are specially commisioned by the Editors-in-Chief. Journal of Inflammation is affiliated with the British Inflammation Research Association (BIRAs).